干扰素和聚肌胞苷酸的抗肿瘤作用及其作为人类抗肿瘤药物的潜在用途。 - Suppr | 超能文献

Antitumor effects of interferon and poly ICLC, and their possible utility as anti-neoplastic agents in man.

作者信息

Levy H B, Levine A S

出版信息

Tex Rep Biol Med. 1981;41:653-62.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Antitumor effects of interferon and poly ICLC, and their possible utility as anti-neoplastic agents in man.干扰素和聚肌胞苷酸的抗肿瘤作用及其作为人类抗肿瘤药物的潜在用途。

Tex Rep Biol Med. 1981;41:653-62.

2

Treatment of recurrent laryngeal papillomatosis with an artificial interferon inducer (poly ICLC).用人造干扰素诱导剂（聚肌胞苷酸）治疗复发性喉乳头状瘤病。

J Pediatr. 1981 Oct;99(4):614-6. doi: 10.1016/s0022-3476(81)80274-0.

3

Interferon induction and therapy of brain tumors in rats by poly(ICLC).聚肌胞苷酸（聚肌苷酸-聚胞苷酸，聚肌胞苷酸）对大鼠脑肿瘤的干扰素诱导及治疗作用

Microbiol Immunol. 1982;26(4):353-8. doi: 10.1111/j.1348-0421.1982.tb00185.x.

4

[Antitumor effect of Corynebacterium parvum and poly ICLC on experimental brain tumors].[短小棒状杆菌和聚肌胞苷酸对实验性脑肿瘤的抗肿瘤作用]

Neurol Med Chir (Tokyo). 1983 Nov;23(11):841-8. doi: 10.2176/nmc.23.841.

5

[Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].干扰素诱导剂（聚肌胞苷酸-聚肌苷酸）治疗恶性脑肿瘤的疗效（作者译）

No To Shinkei. 1982 Mar;34(3):267-73.

6

The effect of interferon on rabies infection of animals.干扰素对动物狂犬病感染的影响。

Tex Rep Biol Med. 1981;41:526-31.

7

Phase I-II trials of poly(ICLC) in malignant brain tumor patients.聚肌胞苷酸-聚左旋赖氨酸-羧甲基纤维素（poly(ICLC)）用于恶性脑肿瘤患者的I-II期试验。

J Interferon Res. 1982;2(1):1-4. doi: 10.1089/jir.1982.2.1.

8

Liver enzyme abnormalities after poly ICLC infusions.聚肌胞苷酸-聚肌苷酸（poly ICLC）输注后的肝酶异常

Cancer Treat Rep. 1985 Nov;69(11):1342.

9

Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)).

Gynecol Oncol. 1986 Jul;24(3):359-61. doi: 10.1016/0090-8258(86)90313-6.

10

Cortisol induction by poly ICLC: implications for clinical trials of interferon.聚肌胞苷酸-聚左旋赖氨酸-羧甲基纤维素钠诱导皮质醇：对干扰素临床试验的意义

Ann Neurol. 1988 Feb;23(2):196-9. doi: 10.1002/ana.410230215.

引用本文的文献

1

Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.聚肌胞预处理通过 I 型干扰素信号通路保护血脑屏障免受体外缺血性损伤。

J Neurochem. 2012 Nov;123 Suppl 2(Suppl 2):75-85. doi: 10.1111/j.1471-4159.2012.07946.x.

2

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.北美脑肿瘤联盟关于聚肌胞苷酸-聚左旋赖氨酸-羧甲基纤维素（poly-ICLC）用于复发性间变性胶质瘤成年患者的II期研究。

J Neurooncol. 2009 Jan;91(2):183-9. doi: 10.1007/s11060-008-9705-3. Epub 2008 Oct 11.

3

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).一项针对新诊断的幕上胶质母细胞瘤成年患者的聚肌胞苷酸-聚左旋赖氨酸-羧甲基纤维素（poly-ICLC）联合放疗的II期临床试验：北美脑肿瘤联盟（NABTC01-05）

J Neurooncol. 2009 Jan;91(2):175-82. doi: 10.1007/s11060-008-9693-3. Epub 2008 Sep 17.